Understanding CHS: The Risks of Chronic Cannabis Use

As cannabis use becomes more popular nationwide, especially among young people, there is a growing movement to educate the public about the potential risks associated with heavy and chronic use. A new American Gastroenterological Association (AGA) clinical practice update shines a light on cannabinoid hyperemesis syndrome (CHS), a condition that is becoming more prevalent as cannabis consumption rises.

A growing number of heavy cannabis users – especially young people – are showing up in emergency rooms with prolonged vomiting due to CHS. Presenters Rebecca M. Cantu, MD, MPH, Brittany M. Slagle, DO, and Sara Sanders, MD discuss the overall prevalence of CHS and the importance of recognizing its symptoms.

The differential diagnosis for a patient with an acute onset of nausea, vomiting, and abdominal pain who presents to an urgent care center may include CHS. Cannabis use in people with type 1 diabetes can raise the risk of diabetic ketoacidosis (DKA) and trigger a condition with similar symptoms called Hyperemesis Ketosis-CHS.

CHS is a medical condition characterized by recurrent nausea, vomiting, and abdominal pain in individuals who are chronic cannabis users. What is CHS? How do nausea and stomach pain lead to a diagnosis and a link to cannabis use? An increasing number of cases are being reported of this mysterious syndrome, prompting further research and awareness.

Chronic weed consumption can lead to CHS. It is important to understand what causes this syndrome, its symptoms, and how to treat and prevent it. Education and awareness are key in addressing the risks associated with chronic cannabis use.